Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in D-A-CH, consisting of Germany, Austria, and Switzerland, has been experiencing steady growth in recent years.
Customer preferences: Customers in D-A-CH are increasingly seeking preventative healthcare measures, including vaccinations, leading to a growing demand for Other Vaccines. Additionally, the aging population in the region has contributed to the growth of the market as older individuals are more susceptible to certain diseases that can be prevented through vaccination.
Trends in the market: One notable trend in the Other Vaccines market in D-A-CH is the increasing popularity of travel vaccines. As more individuals travel internationally, there is a greater need for vaccinations to protect against diseases that may be prevalent in other parts of the world. Another trend is the rising demand for vaccines that protect against sexually transmitted infections, such as HPV and hepatitis B.
Local special circumstances: Germany has the largest market for Other Vaccines in D-A-CH, with a strong emphasis on preventative healthcare. Austria has a smaller market but is known for its high vaccination rates, particularly in children. Switzerland has a unique healthcare system that allows for greater patient choice and autonomy, which has led to a more diverse market for Other Vaccines.
Underlying macroeconomic factors: The strong economy in D-A-CH has allowed for increased spending on healthcare and preventative measures. Additionally, the region's high standard of living and access to healthcare has led to a greater awareness and demand for vaccinations. However, the market is also highly regulated, which can pose challenges for companies looking to enter or expand in the region.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
